4.269411055495999, BRIEF-Chemed Corp Q1 Revenue Rose 11.6% to $516 Million April 28 (Reuters) - Chemed Corp: * Q1 EARNINGS PER SHARE ESTIMATE $3.65 -- REFINITIV IBES DATA * SAYS ANTICIPATES PROVIDING UPDATED 2020 EARNINGS GUIDANCE IN JULY 2020 Source text for Eikon: Further company coverage:
5.211637178888454," BRIEF-Chemed Says Unit Received $80.2 Mln From The Provider Relief Fund April 15 (Reuters) - Chemed Corp: * CHEMED CORP - ON APRIL 10, VITAS HEALTHCARE, UNIT OF CO RECEIVED $80.2 MILLION FROM U.S. FEDERAL GOVERNMENT FROM THE PROVIDER RELIEF FUND Source text: (‍here ) Further company coverage:"
3.5203097170322413," BRIEF-Chemed Corporation’S Board Of Directors Authorizes An Additional $250 Million For Stock Repurchase Chemed Corp: * CHEMED CORPORATION’S BOARD OF DIRECTORS AUTHORIZES AN ADDITIONAL $250 MILLION FOR STOCK REPURCHASE * CHEMED CORP - REPURCHASES WILL BE FUNDED THROUGH CASH FROM OPERATIONS, REVOLVING CREDIT FACILITY Source text for Eikon: Further company coverage:"
-5.181521298935823," BRIEF-Chemed Reports Q4 Adjusted Earnings Per Share $4.22 Feb 18 (Reuters) - Chemed Corp: * Q4 REVENUE $522 MILLION VERSUS REFINITIV IBES ESTIMATE OF $524.2 MILLION * Q4 EARNINGS PER SHARE ESTIMATE $4.09 -- REFINITIV IBES DATA * FULL-YEAR 2020 ADJUSTED EARNINGS PER DILUTED SHARE IS ESTIMATED TO BE IN RANGE OF $16.20 TO $16.50 * FY2020 EARNINGS PER SHARE VIEW $15.63 -- REFINITIV IBES DATA * REVENUE GROWTH FOR VITAS IN 2020, PRIOR TO MEDICARE CAP, IS ESTIMATED TO BE IN RANGE OF 8.5% TO 9.5% * ROTO-ROOTER IS FORECASTED TO ACHIEVE FULL-YEAR 2020 REVENUE GROWTH OF 13.0% TO 14.0% Source text for Eikon: Further company coverage:"
12.393967211305057, BRIEF-Chemed Corp Q1 GAAP Earnings Per Share $2.66 April 19 (Reuters) - Chemed Corp: * Q1 REVENUE $439 MILLION VERSUS I/B/E/S VIEW $419.3 MILLION * Q1 EARNINGS PER SHARE VIEW $2.36 -- THOMSON REUTERS I/B/E/S * COMPANY HAS REITERATED EARNINGS GUIDANCE Source text for Eikon: Further company coverage:
